These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

547 related items for PubMed ID: 16267627

  • 1. Cancer treatment and pharmacogenetics of cytochrome P450 enzymes.
    van Schaik RH.
    Invest New Drugs; 2005 Dec; 23(6):513-22. PubMed ID: 16267627
    [Abstract] [Full Text] [Related]

  • 2. Implications of cytochrome P450 genetic polymorphisms on the toxicity of antitumor agents.
    van Schaik RH.
    Ther Drug Monit; 2004 Apr; 26(2):236-40. PubMed ID: 15228172
    [Abstract] [Full Text] [Related]

  • 3. CYP450 pharmacogenetics for personalizing cancer therapy.
    van Schaik RH.
    Drug Resist Updat; 2008 Jun; 11(3):77-98. PubMed ID: 18486526
    [Abstract] [Full Text] [Related]

  • 4. Cytochrome P450 in Pharmacogenetics: An Update.
    Tornio A, Backman JT.
    Adv Pharmacol; 2018 Jun; 83():3-32. PubMed ID: 29801580
    [Abstract] [Full Text] [Related]

  • 5. Cytochrome P450 pharmacogenetics and cancer.
    Rodriguez-Antona C, Ingelman-Sundberg M.
    Oncogene; 2006 Mar 13; 25(11):1679-91. PubMed ID: 16550168
    [Abstract] [Full Text] [Related]

  • 6. Cancer pharmacogenomics: achievements in basic research.
    Nakajima M, Yokoi T.
    Int J Clin Oncol; 2005 Feb 13; 10(1):14-9. PubMed ID: 15729595
    [Abstract] [Full Text] [Related]

  • 7. Genotyping and phenotyping cytochrome P450: perspectives for cancer treatment.
    Mathijssen RH, van Schaik RH.
    Eur J Cancer; 2006 Jan 13; 42(2):141-8. PubMed ID: 16325399
    [Abstract] [Full Text] [Related]

  • 8. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF, Liu JP, Chowbay B.
    Drug Metab Rev; 2009 Jan 13; 41(2):89-295. PubMed ID: 19514967
    [Abstract] [Full Text] [Related]

  • 9. Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects.
    Sim SC, Kacevska M, Ingelman-Sundberg M.
    Pharmacogenomics J; 2013 Feb 13; 13(1):1-11. PubMed ID: 23089672
    [Abstract] [Full Text] [Related]

  • 10. Pharmacogenetics of the major polymorphic metabolizing enzymes.
    Daly AK.
    Fundam Clin Pharmacol; 2003 Feb 13; 17(1):27-41. PubMed ID: 12588628
    [Abstract] [Full Text] [Related]

  • 11. Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics.
    Deeken JF, Figg WD, Bates SE, Sparreboom A.
    Anticancer Drugs; 2007 Feb 13; 18(2):111-26. PubMed ID: 17159598
    [Abstract] [Full Text] [Related]

  • 12. Cytochrome P450 in Cancer Susceptibility and Treatment.
    Mittal B, Tulsyan S, Kumar S, Mittal RD, Agarwal G.
    Adv Clin Chem; 2015 Feb 13; 71():77-139. PubMed ID: 26411412
    [Abstract] [Full Text] [Related]

  • 13. Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism.
    Rochat B.
    Clin Pharmacokinet; 2005 Feb 13; 44(4):349-66. PubMed ID: 15828850
    [Abstract] [Full Text] [Related]

  • 14. Significant role of CYP450 genetic variants in cyclophosphamide based breast cancer treatment outcomes: a multi-analytical strategy.
    Tulsyan S, Agarwal G, Lal P, Mittal B.
    Clin Chim Acta; 2014 Jul 01; 434():21-8. PubMed ID: 24768782
    [Abstract] [Full Text] [Related]

  • 15. Cancer therapy and polymorphisms of cytochromes P450.
    MacLeod SL, Nowell S, Massengill J, Jazieh A, McClure G, Plaxco J, Kadlubar FF, Lan NP.
    Clin Chem Lab Med; 2000 Sep 01; 38(9):883-7. PubMed ID: 11097344
    [Abstract] [Full Text] [Related]

  • 16. Pharmacogenetics of drug metabolising enzymes: importance for personalised medicine.
    Oscarson M.
    Clin Chem Lab Med; 2003 Apr 01; 41(4):573-80. PubMed ID: 12747605
    [Abstract] [Full Text] [Related]

  • 17. Genetic polymorphisms of drug-metabolising enzymes and drug transporters in the chemotherapeutic treatment of cancer.
    Bosch TM, Meijerman I, Beijnen JH, Schellens JH.
    Clin Pharmacokinet; 2006 Apr 01; 45(3):253-85. PubMed ID: 16509759
    [Abstract] [Full Text] [Related]

  • 18. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
    Ingelman-Sundberg M, Sim SC, Gomez A, Rodriguez-Antona C.
    Pharmacol Ther; 2007 Dec 01; 116(3):496-526. PubMed ID: 18001838
    [Abstract] [Full Text] [Related]

  • 19. African Genetic Diversity: Implications for Cytochrome P450-mediated Drug Metabolism and Drug Development.
    Rajman I, Knapp L, Morgan T, Masimirembwa C.
    EBioMedicine; 2017 Mar 01; 17():67-74. PubMed ID: 28237373
    [Abstract] [Full Text] [Related]

  • 20. Genotypes Affecting the Pharmacokinetics of Anticancer Drugs.
    Bertholee D, Maring JG, van Kuilenburg AB.
    Clin Pharmacokinet; 2017 Apr 01; 56(4):317-337. PubMed ID: 27641154
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.